Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests

Author:

Ashizawa Nobuyuki,Takazono TakahiroORCID,Ohyama Kaname,Nagasaki Yoji,Okamoto Masaki,Hirayama Tatsuro,Takahashi Kensuke,Yamanashi HirotomoORCID,Tashiro MasatoORCID,Hosogaya Naoki,Tanaka Takeshi,Yamamoto Kazuko,Fukuda Yuichi,Imamura Yoshifumi,Kawanami Toshinori,Miyazaki Taiga,Sawai Toyomitsu,Fukushima Kiyoyasu,Yatera Kazuhiro,Yanagihara Katsunori,Izumikawa Koichi,Mukae Hiroshi

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference20 articles.

1. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Annals of internal medicine;Meyerowitz,2020

2. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes;Zhang;Emerg Microb Infect,2020

3. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019;Zhao;Clin Infect Dis : an official publication of the Infectious Diseases Society of America,2020

4. Recent progress on the diagnosis of 2019 novel coronavirus;Li;Transboundary and emerging diseases,2020

5. Laboratory diagnosis of COVID-19: current issues and challenges;Tang;J Clin Microbiol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3